302 related articles for article (PubMed ID: 11151880)
1. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease.
Andoh A; Tsujikawa T; Hata K; Araki Y; Kitoh K; Sasaki M; Yoshida T; Fujiyama Y
Am J Gastroenterol; 2005 Sep; 100(9):2042-8. PubMed ID: 16128950
[TBL] [Abstract][Full Text] [Related]
5. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels.
Español I; Hernández A; Cortés M; Mateo J; Pujol-Moix N
Haematologica; 1999 Apr; 84(4):312-6. PubMed ID: 10190944
[TBL] [Abstract][Full Text] [Related]
6. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
7. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
[TBL] [Abstract][Full Text] [Related]
9. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
[TBL] [Abstract][Full Text] [Related]
10. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
11. Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.
Gu J; Lu L; Xu R; Chen X
Chin Med J (Engl); 2002 Jul; 115(7):983-6. PubMed ID: 12150725
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
13. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Kirazli S; Calgüneri M
Clin Rheumatol; 2002 Nov; 21(6):453-6. PubMed ID: 12447626
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
16. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
17. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?
Zissis M; Afroudakis A; Galanopoulos G; Palermos L; Boura X; Michopoulos S; Archimandritis A
Am J Gastroenterol; 2001 Jul; 96(7):2177-83. PubMed ID: 11467650
[TBL] [Abstract][Full Text] [Related]
18. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
[TBL] [Abstract][Full Text] [Related]
19. [The relationship among the counts of platelet, thrombopoietin and spleen index in patients with liver cirrhosis].
Li Q; Sun GZ; Wang BE; Jia JD; Ma H; Wei YX; Cong YL; Shen J
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):210-2. PubMed ID: 15099468
[TBL] [Abstract][Full Text] [Related]
20. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
